[Primary systemic amyloidosis with polyneuropathy as the major symptom demonstrating marked myocardial uptake of technetium-99m-hydroxy methylene diphosphonate].
D000686:Amyloidosis / Q000000981:diagnostic imaging* / Q000473:pathology; D009202:Cardiomyopathies / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D010523:Peripheral Nervous System Diseases / Q000150:complications*; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives*
C024226:technetium Tc 99m hydroxymethylene diphosphonate; D013669:Technetium Tc 99m Medronate